- Home
- EUDA vs PYXS Comparison
EUDA vs PYXS Comparison
Compare EUDA & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EUDA | PYXS |
|---|---|---|
| Founded | 2021 | 2018 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 82.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | EUDA | PYXS |
|---|---|---|
| Price | $10.58 | $1.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $55.00 | $7.00 |
| AVG Volume (30 Days) | 167.2K | ★ 307.8K |
| Earning Date | 12-19-2023 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,858,000.00 |
| Revenue This Year | $134.73 | N/A |
| Revenue Next Year | $195.03 | N/A |
| P/E Ratio | $123.62 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.33 | $0.84 |
| 52 Week High | $15.36 | $5.55 |
Technical Indicators
Market Signals| Indicator | EUDA | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 90.22 | 37.64 |
| Support Level | $1.53 | $1.01 |
| Resistance Level | N/A | $1.31 |
| Average True Range (ATR) | 0.83 | 0.11 |
| MACD | 1.22 | -0.02 |
| Stochastic Oscillator | 70.73 | 3.49 |
Price Performance
Historical ComparisonAbout EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.